$3 million in Series A investment was secured by OptMyCare, a Dallas, Texas-based supplier of a clinically developed AI healthcare and risk management platform.
Total amount
The round, which increased the sum to $4.5 million overall.
Investor
LiveOak Ventures
Use of funds
The money will be used by the business to expand its client acquisition strategies, keep improving its technology, hire more seasoned professionals in healthcare and technology, and onboard key management staff.
About OptMyCare
OptMyCare is a scalable, secure, cloud-based software as a service (SaaS) product that was founded in 2019 by Drs. Antony E. Pfaffle, MD, and Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN. It combines precision analytics with practical risk stratification solutions for a variety of chronic conditions and generates recommendations based on real-time input. Using data from 55 chronic clinical conditions, together with related procedures and claims costs, the solution uses clinically-engineered algorithms to quickly and accurately identify risks.
